ArticleFrontiers in oncology2021

Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer.

Zhenghang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.